Skip to main content
Premium Trial:

Request an Annual Quote

Signature Genomic Laboratories

Signature Genomic Laboratories this week launched SignatureChip Oligo Solution for the detection of chromosome abnormalities in individuals with mental retardation, developmental delay, and congenital anomalies.
The 105,000 oligonucleotides on the array cover over 150 syndromes. SignatureChipOS has one probe every 10 kilobases in regions of interest and an average probe spacing of one probe every 35 kb throughout the genome, for an average of 50 oligos per clinical locus, the firm said.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.